C
Ch. Legendre
Researcher at Paris Descartes University
Publications - 47
Citations - 4416
Ch. Legendre is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 23, co-authored 47 publications receiving 3933 citations. Previous affiliations of Ch. Legendre include Necker-Enfants Malades Hospital.
Papers
More filters
Journal ArticleDOI
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Ch. Legendre,Christoph Licht,Petra Muus,Laurence Greenbaum,Sunil Babu,C. Bedrosian,C. Bingham,David J. Cohen,Y. Delmas,Kenneth W. Douglas,Frank Eitner,Thorsten Feldkamp,Denis Fouque,Richard R. Furman,Osama Gaber,Maria Herthelius,Maryvonne Hourmant,Diana Karpman,Yvon Lebranchu,Christophe Mariat,Jan Menne,Bruno Moulin,Jens Nürnberger,Masayo Ogawa,Giuseppe Remuzzi,T. Richard,Rebecca Sberro-Soussan,B. Severino,Neil S. Sheerin,Antonella Trivelli,L.B. Zimmerhackl,Timothy H.J. Goodship,Chantal Loirat +32 more
TL;DR: Eculizumab inhibited complement-mediated thrombotic microangiopathy and was associated with significant time-dependent improvement in renal function in patients with atypical hemolytic-uremic syndrome and was also associated with improvement in health-related quality of life.
Journal ArticleDOI
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
Alexandre Loupy,Mark Haas,Kim Solez,Lorraine C. Racusen,Denis Glotz,Daniel Serón,Brian J. Nankivell,Robert B. Colvin,Marjan Afrouzian,Enver Akalin,Nada Alachkar,Serena M. Bagnasco,Jan U. Becker,Lynn D. Cornell,Cinthia B. Drachenberg,Duska Dragun,H. de Kort,Ian W. Gibson,Edward S. Kraus,Carmen Lefaucheur,Ch. Legendre,Helen Liapis,Thangamani Muthukumar,Volker Nickeleit,Babak J. Orandi,Walter D. Park,Marion Rabant,Parmjeet Randhawa,Elaine F. Reed,Candice Roufosse,Surya V. Seshan,Banu Sis,Harsharan K. Singh,Carrie A. Schinstock,Anat R. Tambur,A. Zeevi,Michael Mengel +36 more
TL;DR: Improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification are included.
Journal ArticleDOI
Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients
TL;DR: It is suggested that hydroxyethylstarch used as a plasma-volume expander in brain-dead donors impairs immediate renal function in kidney-transplant recipients.
Journal ArticleDOI
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected].
Lucienne Chatenoud,Christiane Ferran,Aimee Reuter,Ch. Legendre,Gevaert Y,Henri Kreis,Paul Franchimont,Jean-François Bach +7 more
Journal ArticleDOI
Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation
Julien Zuber,M. Le Quintrec,Saoussen Krid,C. Bertoye,V. Gueutin,Annie Lahoche,Nils Heyne,Gianluigi Ardissino,Valérie Chatelet,L.-H. Noël,Maryvonne Hourmant,Niaudet P,Véronique Frémeaux-Bacchi,Eric Rondeau,Ch. Legendre,Chantal Loirat +15 more
TL;DR: Data suggest that long‐term eculizumab is highly effective for preventing and treating posttransplant aHUS recurrence, and indicates that anti‐C5 should be promptly started if a recurrence occurs.